| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 振德以“让健康生活触手可及”为品牌大理想，产品线涵盖包扎与固定、创面护理、手术感控、基础护理、防护隔离、压力治疗与VTE预防、造口失禁护理、高端伤口护理、个人护理、康复护理、静疗护理等不同使用场景。拥有5个国内生产基地，3个海外工厂（2个在筹建中），并设有覆盖国内所有省区市的销售网络。振德医疗的产品与解决方案已服务于以欧美为主的全球70多个国家和地区，及中国近万家医疗机构，其中三甲医院超过1100家，12万多家药店，在线上作为TOP商家，电商渠道合计粉丝量超835万人。目前，振德医疗在手术感控与防护用品、压力治疗等细分市场保持品牌号召力和领先优势。 公司产品通过美国FDA、欧盟CE、ISO13485医疗器械质量管理体系认证和中国CFDA认证。专注于产品的研发投入与创新，持续推进质量体系、流程数字化和智能工厂，提高公司整体经营效率，并提升快速响应客户需求的能力。 未来，振德医疗将更加关注人才建设、品牌建设和可持续发展，不断提升组织竞争力，以专业的临床医学作为支撑，不断优化端到端的交付能力，为医疗运动防护与家庭护理，提供更完善的产品解决方案，致力于成为全球医疗用品和家庭护理解决方案领域的主流企业。 | ||||||||||||||||||||||||
| Main Business | 医用敷料的生产、研发与销售 | ||||||||||||||||||||||||
| Legal Representative | 鲁建国 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 季宝海 | ||||||||||||||||||||||||
| Solicitors | 浙江天册律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0575-88751963 | ||||||||||||||||||||||||
| Fax No | 0575-88751963 | ||||||||||||||||||||||||
| Website | www.zhende.com | ||||||||||||||||||||||||
| dsh@zhende.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 12/04/2018 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.740 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 1.250 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 20.137 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 6.294B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |